Automated detection algorithm for C4d immunostaining showed comparable diagnostic performance to pathologists in renal allograft biopsy
- 1 August 2020
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 33 (8), 1626-1634
- https://doi.org/10.1038/s41379-020-0529-9
Abstract
No abstract availableFunding Information
- Asan Institute for Life Sciences, Asan Medical Center (2018-7028)
This publication has 29 references indexed in Scilit:
- A Review on Color Normalization and Color Deconvolution Methods in HistopathologyApplied Immunohistochemistry & Molecular Morphology, 2014
- Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial LesionsAmerican Journal of Transplantation, 2014
- Banff Initiative for Quality Assurance in Transplantation (BIFQUIT): Reproducibility of C4d Immunohistochemistry in Kidney AllograftsAmerican Journal of Transplantation, 2013
- Antibody-Mediated Rejection After Alemtuzumab Induction: Incidence, Risk Factors, and Predictors of Poor OutcomeTransplantation, 2011
- Significance of C4d Banff Scores in Early Protocol Biopsies of Kidney Transplant Recipients with Preformed Donor-Specific Antibodies (DSA)American Journal of Transplantation, 2010
- Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant FailureAmerican Journal of Transplantation, 2009
- C4d and C3d Staining in Biopsies of ABO- and HLA-Incompatible Renal Allografts: Correlation with Histologic FindingsAmerican Journal of Transplantation, 2006
- Protocol Transplant Biopsies in Kidney AllograftsClinical Journal of the American Society of Nephrology, 2006
- Kidney transplants, antibodies and rejection: is C4d a magic marker?Nephrology Dialysis Transplantation, 2003
- International variation in the interpretation of renal transplant biopsies: Report of the CERTPAP Project11A complete listing of the participants who all contributed equally to the work of the CERTPAP Project includes Peter N. Furness (Leicester, UK); Nicholas Taub (Leicester, United Kingdom); Karel J.M. Assmann (Nijmegen, The Netherlands); Giovanni Banfi (Milan, Italy); John N. Botelis (Athens, Greece); Marta Carrera (Barcelona, Spain); Jean-Pierre Cosyns (Brussels, Belgium); Anthony M. Dorman (Dublin, Ireland); Dominique Droz (Paris, France); Claire M. Hill (Belfast, N. Ireland); Bela Iványi (Kossuth, Hungary); Silke Kapper (Mannheim, Germany); Erik N. Larsson (Uppsala, Sweden); Aryvdas Laurinavicius (Vilius, Lithuania); Niels Marcussen (Aachus, Denmark); Anna Paula Martins (Lisbon, Portugal); Michael J. Mihatsch (Basel, Switzerland); Lydia Nakopoulou (Athens, Greece); Volker Nickeleit (Basel, Switzerland); L-H Nöel (Paris, France); Timo Paavonen (Helsinki, Finland); Agnieszua K. Perkowska (Warsaw, Poland); Heinz Regele (Vienna, Austria); Rafail Rosenthal (Riga, Latvia); Pavel Rossmann (Prague, Czech Republic); Wotgech A. Rowinski (Warsaw, Poland); Daniel Seron (Barcelona, Spain); Stale Sund (Oslo, Norway); Eero I. Taskinen (Helsinki, Finland); Tatjana Tihomirova (Riga, Latvia); and Rudiger Waldherr (Mannheim, Germany).Kidney International, 2001